Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listings
Events
More
Strategic Alliance Partners
Sponsored

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Subscribe
  • Strategic Alliance Partners
  • Sponsored
  • Fibromyalgia
  • Gout
  • Lupus
    • Lupus Nephritis
    • Cutaneous Lupus Erythematosus
    • Systemic Lupus Erythematosus
  • Osteoarthritis
  • Osteoporosis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Sjögren's Disease
  • Spondyloarthritis
    • Axial spondyloarthritis
    • Nonradiographic axial spondyloarthritis
Spotlight -
FDA News
Advertisement

Laurence Duquenne, MD, PhD

Advertisement
Laurence Duquenne, MD, PhD

University of Leeds

Articles by Laurence Duquenne, MD, PhD

Joint Ventures: Aiming for Targeted First-Line Therapy in Early RA at EULAR 2026

Joint Ventures: Aiming for Targeted First-Line Therapy in Early RA at EULAR 2026

ByJack Arnold, MBBS, MRCP, PhD,Laurence Duquenne, MD, PhD
June 23rd 2026

Laurence Duquenne, MD, PhD, joins Joint Ventures to discuss the TEEMS trial and T-cell stratification.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Rheumatology Live

    1

    Nipocalimab, Telitacicept, and the Sjögren’s Disease Pipeline

    2

    Dazodalibep Eases Sjögren’s Dryness via CD40L Blockade: Ghaith Noaiseh, MD

    3

    Dazodalibep Lowers Sjögren’s Disease Activity: Ghaith Noaiseh, MD

    4

    INDIGO: Obexelimab Sustains IgG4-RD Flare Control, With John Stone, MD, MPH

    5

    Selecting Sjögren’s Patients for Ianalumab and Weighing Safety

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Do Not Sell My Information
    • Privacy
    • Terms & Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    • Contagion Live
    • CGT Live
    • Neurology Live
    • HCP Live
    • Oncology Live
    • Contemporary Pediatrics
    • Contemporary OBGYN
    • Urology Times
    • The Educated Patient
    Rheumatology Live
    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    News
    Contact Us